Role of epigenetics in cancer health disparities

Methods in Molecular Biology

Volumn 863, Issue , 2012, Pages 395-410

  Mohammed, Sulma I ^a   Springfield, Sanya ^b   Das, Rina ^b  

^a PURDUE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer disparities; DNA methylation; Epigenetics; Ethnic; Race

Indexed keywords

ARTICLE; DNA METHYLATION; EPIGENETICS; GENETIC EPIGENESIS; GENETICS; HEALTH DISPARITY; HUMAN; INCIDENCE; METHODOLOGY; NEOPLASM; PHYSIOLOGY; RACE;

CONTINENTAL POPULATION GROUPS; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; NEOPLASMS;

EID: 84860004877     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-612-8_25     Document Type: Article

References (82)

1. Jemal, A., Siegel, R., Xu, J. and Ward, E. (2010) Cancer Statistics, 2010. CA Cancer J. Clin. 60, 277-300.
2. McCracken, M., Olsen, M., Chen, M.S. Jr., Jemal, A., Thun, M., Cokkinides, V., Deapen, D. and Ward, E. (2007) Cancer Incidence, Mortality, and Associated Risk Factors Among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese Ethnicities. CA Cancer J. Clin. 57, 190-205. (Pubitemid 47312080)
3. Chen, M.S. Jr. (2005) Cancer health disparities among Asian Americans: What we do and what we need to do. Cancer 104, 2895-902. (Pubitemid 41798252)
4. Albain, K.S., Unger, J.M., Crowley, J.J., Coltman, C.A. Jr. and Hershman, D.L. (2009) Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group . J Natl. Cancer Inst. 101, 984-992.
5. Godley, P.A., Schenck, A.P., Amamoo, M.A., Schoenbach, V.J., Peacock, S., Manning, M., Symons, M. and Talcott, J.A. (2003) Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. J Natl. Cancer Inst. 95, 1702-1710. (Pubitemid 37509079)
6. Chu, K.C., Miller, B.A., and Springfi eld, S. A. (2007) Measures of racial/ethnic health disparities in cancer mortality rates and the infl uence of socioeconomic status. J Nat Med Assoc 99, 1092-1100.
7. Freedman, H. and Chu, K. (2005) Determinants of cancer disparities: Barriers to cancer screening, diagnosis, and treatment. Surg. Oncol. Clin N Am 14, 655-669. (Pubitemid 41446311)
8. Rotimi, C.N. and Jorde, L.B. (2010) Ancestry and disease in the age of genomic medicine. N. Engl. J. Med. 363, 1551-1558.
9. Ingelman-Sundberg, M. (2008) Pharmacogenomic biomarkers for prediction of severe adverse drug reactions. N. Engl. J. Med. 358, 637-639. (Pubitemid 351214293)
10. Phan, V.H., Moore, M.M., McLachlan, A.J., Piquette-Miller, M., Xu, H. and Clarke, S.J. (2009) Ethnic differences in drug metabolism and toxicity from chemotherapy. Expert Opin. Drug Metab. Toxicol 5, 243-257.
11. Verma, M. and Srivastava, S. (2002) Epigenetics in cancer: Implications for early detection and prevention. Lancet Oncol 3, 755-763. (Pubitemid 35446745)
12. Jones, P.A. and Baylin, S.B. (2007) The epigenomics of cancer. Cell 128, 683-692. (Pubitemid 46273572)
13. McGowan, P.O., Meaney, M.J. and Szyf, M. (2008) Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Res 1237, 12-24.
14. Mathers, J.C., Strathdee, G. and Relton, C.L. (2010) Induction of epigenetic alterations by dietary and other environmental factors Advances in Genetics 71, 3-39.
15. Fang, M.Z., Chen, D., Sun, Y., Jin, Z., Christman, J.K. and Yang, C.S. (2005) Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isofl avones from soy. Clin. Cancer Res. 11, 7033-7041. (Pubitemid 41428763)
16. Duthie, S.J. (2010) Epigenetic modifi cations and human pathologies: Cancer and CVD. Proc Nutr Soc 11, 1-10.
17. Williams, C.D., Satia, J.A., Adair, L.S., Stevens, J., Galanko, J., Keku, T.O. and Sandler, R.S. (2009) Dietary patterns, food groups, and rectal cancer risk in Whites and African-Americans. Cancer Epidemiol. Biomarkers Prev. 18, 1552-1561.
18. Krukowski, R.A. and West, D.S. (2010) Consideration of the food environment in cancer risk reduction. J Am Diet Assoc 110, 842-844.
19. Watters, J.L., Satia, J.A., Kupper, L.L., Swenberg, J.A., Schroeder, J.C. and Switzer, B.R. (2007) Associations of antioxidant nutrients and oxidative DNA damage in healthy African-American and White adults. Cancer Epidemiol. Biomarkers Prev. 16, 1428-1436. (Pubitemid 47076874)
20. Lechner, M., Boshoff, C. and Beck, S. (2010) Cancer epigenome. Adv Genet 70, 247-276.
21. Feinberg, A.P. (2010) Epigenomics reveals a functional genome anatomy and a new approach to common disease. Nat. Biotechnol. 28 , 1049-1052.
22. Ray, M. and Polite, B. N. (2010) Triple Negative Breast Cancers- A view from 10,000 feet. Cancer J 16, 17-22.
23. Amend, K., Hicks, D. and Ambrosone, C.B. (2006) Breast Cancer in African-American Women: Differences in Tumor Biology from European-American Women. Cancer Res. 66, 8327-8330. (Pubitemid 44449138)
24. Hayanga, A.J. and Newman, L.A. (2007) Investigating the phenotypes and genotypes of breast cancer in women with African ancestry: The need for more genetic epidemiology. Surg Clin North Am 87, 551-568. (Pubitemid 46693949)
25. Agurs-Collins, T., Dunn, B.K., Browne, D., Johnson, K.A. and Lubet, R. (2010) Epidemiology of health disparities in relation to the biology of estrogen receptor-negative breast cancer. Semin. Oncol. 37, 384-401.
26. Rakha, E. and Reis-Filho, J. (2009) Basal like Breast carcinoma. Arch Pathol Lab Med 133, 860-868.
27. Patel, T. A., Colon-Otero, G., Bueno Hume, C., Copland, J.A. 3 rd. and Perez, E.A. (2010) Breast cancer in Latinas: Gene Expression, Differential Response to Treatments, and Differential Toxicities in Latinas Compared with Other Population Groups. The Oncologist 15, 466-475.
28. Kurian, A.W. (2010) BRCA1 and BRCA2 mutations across race and ethnicity: Distribution and clinical implications. Curr Opin Obstet Gynecol 22, 72-78.
29. Kato, I., Cichon, M., Yee, C.L., Land, S., and Korczak, J.F. (2009) African Americanpreponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer. Cancer Epidemiol 33, 24-30.
30. Sowers, M. R., Wilson, A.L., Kardia, S.R., Chu, J. and McConnell, D.S. (2006) CYP1A1 and CYP1B1 Polymorphisms and Their Association with Estradiol and Estrogen Metabolites in Women Who Are Premenopausal and Perimenopausal. The Am. J. of Med 119, S44-S51. (Pubitemid 44292102)
31. Olopade, O. I., Fackenthal, J.D., Dunston, G., Tainsky, M.A., Collins, F. and Whitfi eld-Broome, C. (2003) Breast cancer genetics in African Americans. Cancer 97, 236-245. (Pubitemid 36033845)
32. Rose, D.P. and Royak-Schaler, R. (2001) Tumor biology and prognosis in black breast cancer patients: A review. Cancer Detect Prev 25, 16-31.
33. Weston, A. and Godbold, J.H. (1997) Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: A meta-Analysis. Environ Health Perspect 105, 919-926. (Pubitemid 27372982)
34. Joe, A.K., Arber, N., Bose, S., Heitjan, D., Zhang, Y., Weinstein, I.B. and Hibshoosh, H. (2001) Cyclin D1 overexpression is more prevalent in non-Caucasian breast cancer. Anticancer Res 21, 3535-3539. (Pubitemid 34224262)
35. John, E.M., Miron, A., Gong,G., Phipps, A.I., Felberg, A., Li, F.P., West, D.W. and Whittemore, A.S. (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298, 2869-2876.
36. Jing, F., Yuping, W., Yong, C., Jie, L., Jun, L., Xuanbing, T. and Lihua, H. (2010) CpG island methylator phenotype of multigene in serum of sporadic breast carcinoma. Tumour Biol 31, 321-331.
37. Guendel, I., Carpio, L., Pedati, C., Schwartz, A., Teal, C., Kashanchi, F. and Kehn-Hall, K. (2010) Methylation of the tumor suppressor protein, BRCA1, infl uences its transcriptional cofactor function. PLoS One 5, e11379.
38. Lee, J. S., Fackler, M.J., Lee, J.H., Choi, C., Park, M.H., Yoon, J.H., Zhang, Z. and Sukumar, S. (2010) Basal-like breast cancer displays distinct patterns of promoter methylation. Cancer Biol Ther 9, 1017-1024.
39. Karray-Chouayekh, S., Trifa, F., Khabir, A., Boujelbane, N., Sellami-Boudawara, T., Daoud, J., Frikha, M., Gargouri, A. and Mokdad-Gargouri, R. (2009) Clinical Signifi cance of Epigenetic Inactivation of hMLH1 and BRCA1 in Tunisian Patients with Invasive Breast Carcinoma. J of Biomed and Biotech 2009, 369129.
40. Dumitrescu, R.G., Marian, C., Krishnan, S.S., Spear, S.L., Kallakury, B.V., Perry, D.J., Convit, J.R., Seillier-Moiseiwitsch, F., Yang, Y., Freudenheim, J.L. and Shields, P.G. (2010) Familial and racial determinants of tumour suppressor genes promoter hypermethylation in breast tissues from healthy women. J Cell Mol Med 14, 1468-1475.
41. Mehrotra, J., Ganpat, M.M., Kanaan, Y., Fackler, M.J., McVeigh, M., Lahti-Domenici, J., Polyak, K., Argani, P., Naab, T., Garrett, E., Parmigiani, G., Broome, C. and Sukumar, S. (2004) Estrogen Receptor/Progesterone Receptor-Negative Breast Cancers of Young African-American Women Have a Higher Frequency of Methylation of Multiple Genes than Those of Caucasian Women. Clin. Cancer Res. 10, 2052-2057. (Pubitemid 38375566)
42. Fackler, M. J., McVeigh, M., Evron, E., Garrett, E., Mehrotra, J., Polyak, K., Sukumar, S. and Argani, P. (2003) DNA methylation of RASSF1A, HIN-1, RAR-b, Cyclin D2 and Twist in in situ invasive and lobular carcinoma. Int J Cancer 107, 970-975. (Pubitemid 37429839)
43. Karray-Chouayekh, S., Trifa, F., Khabir, A., Boujelbane, N., Sellami-Boudawara, T., Daoud, J., Frikha, M., Jlidi, R., Gargouri, A. and Mokdad-Gargouri, R. (2010) Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients. J Cancer Res. Clin. Oncol. 136, 203-210.
44. Hsing, A.W., Tsao L., and Devesa S.S. (2000) International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85, 60-67.
45. Odedina, F.T., Akinremi, T.O., Chinegwundoh, F., Roberts, R., Yu, D., Reams, R.R., Freedman, M.L., Rivers, B., Green, B.L., Kumar, N. (2009) Prostate cancer disparities in Black men of African descent: A comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer 4, Suppl 1:S2
46. Robbins, C., Torres, J.B., Hooker, S., Bonilla, C., Hernandez, W., Candreva, A., Ahaghotu, C., Kittles, R. and Carpten, J. (2007) Confi rmation study of prostate cancer risk variants at 8q24 in African Americans identifi es a novel risk locus. Genome Res 17, 1717-1722. (Pubitemid 351359995)
47. Xu, J., Kibel, A.S., Hu, J.J., Turner, A.R., Pruett, K., Zheng, S.L., Sun, J., Isaacs, S.D., Wiley, K.E., Kim, S.T., Hsu, F.C., Wu, W., Torti, F.M., Walsh, P.C., Chang, B.L. and Isaacs, W.B. (2007) Prostate cancer risk associated loci in African Americans . Cancer Epidemiol. Biomarkers Prev. 18, 2145-2149.
48. Rokman, A., Ikonen, T., Seppälä, E.H., Nupponen, N., Autio, V., Mononen, N., Bailey-Wilson, J., Trent, J., Carpten, J., Matikainen, M.P., Koivisto, P.A., Tammela, T.L., Kallioniemi, O.P. and Schleutker, J. (2004) Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am. J. Hum. Genet. 70, 1299-1304.
49. Kittles, R., Young, D., Weinrich, S., Hudson, J., Argyropoulos, G., Ukoli, F., Adams-Campbell, L. and Dunston, G.M. (2001) Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: Implications for prostate cancer risk. Hum. Genet. 109, 253-261. (Pubitemid 32926918)
50. Rose, R.K., Bernstein, L., Lobo, R.A., Shimizu, H., Stanczyk, F.Z., Pike, M.C. and Henderson, B.E. (1992) 5-Alpha-reducing activity and risk of prostate cancer among Japanese and US white and black males. Lancet 339, 887-889.
51. Kwabi-Addo, B., Wang, S., Chung, W., Jelinek, J., Patierno, S.R., Wang, B.D., Andrawis, R., Lee, N.H., Apprey, V., Issa, J.P. and Ittmann, M. (2010) Identifi cation of differentially methylated genes in normal prostate tissues from African American and Caucasian men. Clin. Cancer Res. 16, 3539-3547.
52. Enokida, H., Shiina, H., Urakami, S., Igawa, M., Ogishima, T., Pookot, D., Li, L.C., Tabatabai, Z.L., Kawahara, M., Nakagawa, M., Kane, C.J., Carroll, P.R. and Dahiya, R. (2005) Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer 116, 174-181. (Pubitemid 40967252)
53. Li, L.C. and Dahiya, R. (2007) Epigenetics of prostate cancer. Frontiers in Bioscience 12, 3377-3397.
54. Woodson, K., Hayes, R., Wideroff, L., Villaruz, L. and Tangrea, J. (2003) Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites. Prostate 55, 199-205. (Pubitemid 36532399)
55. Enokida, H., Shiina, H., Urakami, S., Terashima, M., Ogishima, T., Li, L.C., Kawahara, M., Nakagawa, M., Kane, C.J., Carroll, P.R., Igawa, M. and Dahiya, R. (2006) Smoking infl uences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma. Cancer 106, 79-86. (Pubitemid 43032551)
56. SEER Cancer Statistics Review 1975-2007 http://seer.cancer.gov/csr/1975- 2007/index.html
57. Sharma, S.O. and Keefe, S. J. (2007) Environmental infl uences on the high mortality from colorectal cancer in African Americans. Postgrad Med J 83, 583-589. (Pubitemid 47425609)
58. Chien, C., Morimoto, L.M., Tom, J. and Li, C.I. (2005) Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer 104, 629-639. (Pubitemid 41022822)
59. Goodman, J.E., Bowman, E.D., Chanock, S.J., Alberg, A.J. and Harris, C.C. (2004) Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis 25: 2467-2472. (Pubitemid 39625188)
60. Brim, H., Mokarram, P., Naghibalhossaini, F., Saberi-Firoozi, M., Al-Mandhari, M., et al. (2008) Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study. Mol. Cancer 7, 68.
61. Kumar, K., Brim, H., Giardiello, F., Smoot, D.T., Nouraie, M., Lee, E.L. and Ashktorab, H. (2009) Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans. Clin. Cancer Res. 15, 1155-1161.
62. Ashktorab, H., Begum, R., Akhgar, A., Smoot, D.T., Elbedawi, M., Daremipouran, M., Zhao, A., Momen, B. and Giardiello, F.M. (2007) Folate status and risk of colorectal polyps in African Americans. Dig Dis Sci 52, 1462-1470. (Pubitemid 46776481)
63. Sweeney, C., Curtin, K., Murtaugh, M.A., Caan, B.J., Potter, J.D. and Slattery, M.L. (2006) Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers. Cancer Epidemiol. Biomarkers Prev. 15, 744-749.
64. Ashktorab, H., Schäffer, A.A., Daremipouran, M., Smoot, D.T., Lee, E. and Brim, H. (2010) Distinct genetic alterations in colorectal cancer. PLoS One 5, e8879.
65. Jang, Y.H., Lim, S.B., Kim, M.J., Chung, H.J., Yoo, H.W., Byeon, J.S., Myung, S.J., Lee, W., Chun, S. and Min, W.K. (2010) Three novel mutations of the APC gene in Korean patients with familial adenomatous polyposis. Cancer Genet Cytogenet 200, 34-39.
66. Sheng, J.Q., Cui, W.J., Fu, L., Jin, P., Han, Y., Li, S.J., Fan, R.Y., Li, A.Q., Zhang, M.Z. and Li, S.R. (2010) APC gene mutations in Chinese familial adenomatous polyposis patients. World J Gastroenterol 16, 1522-1526.
67. Mokarram, P., Kumar, K., Brim, H., Naghibalhossaini, F., Saberi-fi roozi, M., Nouraie, M., Green, R., Lee, E., Smoot, D.T. and Ashktorab, H. (2009)Distinct high-profi le methylated genes in colorectal cancer. PLoS One 4, e7012.
68. Ashktorab, H., Belgrave, K., Hosseinkhah, F., Brim, H., Nouraie, M., Takkikto, M., Hewitt, S., Lee, E.L., Dashwood, R.H. and Smoot, D. (2009) Global Histone H4 acetylation and HDAC2 expression in colon adenoma and carcinoma. Dig Dis Sci 54, 2109-2117.
69. Williams, C.D. (2010) Antioxidant and DNA methylation-related nutrients and risk of distal colorectal cancer. Cancer Causes Control 21, 1171-1181.
70. Ma, G.X., Shive, S.E., Fang, C.Y., Feng, Z., Parameswaran, L., Pham, A. and Khanh, C. (2007) Knowledge, attitudes, and behaviors of hepatitis B screening and vaccination and liver cancer risks among Vietnamese Americans. J Health Care Poor Underserved 18, 62-73.
71. Kwong, S.L., Stewart, S.L., Aoki, C.A. and Chen, M.S. Jr. (2010) Disparities in Hepatocellular Carcinoma Survival among Californians of Asian Ancestry, 1988 to 2007. Cancer Epidemiol. Biomarkers Prev. 19, 2747-2757.
72. Zhang, H., Zhai, Y., Hu, Z., Wu, C., Qian, J., Jia, W., Ma, F., Huang, W., Yu, L., Yue, W., Wang, Z., Li, P., Zhang, Y., Liang, R., Wei, Z., Cui, Y., Xie, W., Cai, M., Yu, X., Yuan, Y., Xia, X., Zhang, X., Yang, H., Qiu, W., Yang, J., Gong, F., Chen, M., Shen, H., Lin, D., Zeng, Y.X., He, F. and Zhou, G. (2010) Genomewide association study identifi es 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat. Genet. 42, 755-758.
73. Li, Y., Xie, Q., Lu, F., Zhao, J., Mao, P., Li, Z., Liu, S. and Zhuang, H. (2010) Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients. Liver Int 30, 112-118.
74. Podar, K., and Anderson, K.C. (2005) The pathophysiologic role of VEGF in hematologic malignancies: Therapeutic implications. Blood 105, 1383-1395. (Pubitemid 40223651)
75. Wu, L.M., Xie, H.Y., Zhou, L., Yang, Z., Zhang, F. and Zheng, S.S. (2009) A single nucleotide polymorphism in the vascular endothelial growth factor gene is associated with recurrence of hepatocellular carcinoma after transplantation. Arch Med Res 40, 565-570.
76. Ping, J., Wang, H., Huang, M. and Liu, Z.S. (2006) Genetic analysis of glutathione S-Transferase A1 polymorphism in the Chinese population and the infl uence of genotype on enzymatic properties. Toxicol Sci 89, 438-443. (Pubitemid 43126002)
77. Fang, W., Piao, Z., Buyse, I.M., Simon, D., Sheu, J.C., Perucho, M. and Huang, S. (2001) Preferential loss of a polymorphic RIZ allele in human hepatocellular carcinoma. Br J Cancer 84, 743-747. (Pubitemid 32275645)
78. Tong, M. J., Chavalitdhamrong, D., Lu, D.S., Raman, S.S., Gomes, A., Duffy, J.P., Hong, J.C. and Busuttil, R.W. (2010) Survival in Asian Americans after treatments for hepatocellular carcinoma: A seven-year experience at UCLA. J. Clin. Gastroenterol 44, e63.
79. Feng, Q., Stern, J.E., Hawes, S.E., Lu, H., Jiang, M. and Kiviat, N.B. (2010) DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection. Exp Mol Pathol 88, 287-292.
80. Sugawara, W., Haruta, M., Sasaki, F., Watanabe, N., Tsunematsu, Y., Kikuta, A. and Kaneko, Y. (2007) Promoter hypermethylation of the RASSF1A gene predicts the poor outcome of patients with hepatoblastoma. Pediatr Blood Cancer 49, 240249.
81. Ezzikouri, S., El Feydi, A.E., Benazzouz, M., Afi fi , R., El Kihal, L., Hassar, M., Akil, A., Pineau, P. and Benjelloun, S. (2009) Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population. Infect Genet Evol 9, 877-881.
82. Herath, N.I., Purdie, D.M., Kew, M.C., Smith, J.L., Young, J., Leggett, B.A. and MacDonald, G.A. (2009) Varying etiologies lead to different molecular changes in Australian and South African hepatocellular carcinomas. Int J Oncol 35, 1081-1089.